ROVERO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 23.048
EU - Europa 12.744
AS - Asia 3.198
OC - Oceania 301
AF - Africa 155
SA - Sud America 78
Continente sconosciuto - Info sul continente non disponibili 4
Totale 39.528
Nazione #
US - Stati Uniti d'America 22.968
RU - Federazione Russa 4.624
IT - Italia 1.589
IE - Irlanda 1.531
PL - Polonia 1.430
SE - Svezia 1.347
SG - Singapore 1.056
HK - Hong Kong 736
CN - Cina 613
UA - Ucraina 500
DE - Germania 482
FI - Finlandia 462
CH - Svizzera 367
AU - Australia 297
IN - India 282
GB - Regno Unito 205
JO - Giordania 165
TR - Turchia 114
CI - Costa d'Avorio 113
VN - Vietnam 78
FR - Francia 70
CA - Canada 67
BR - Brasile 66
ID - Indonesia 61
KR - Corea 40
ES - Italia 38
NL - Olanda 38
SC - Seychelles 31
JP - Giappone 23
BE - Belgio 14
MX - Messico 11
GR - Grecia 8
RO - Romania 8
CO - Colombia 6
IL - Israele 6
PK - Pakistan 6
AT - Austria 5
CZ - Repubblica Ceca 5
MU - Mauritius 5
BG - Bulgaria 4
DK - Danimarca 4
EU - Europa 4
HU - Ungheria 4
IR - Iran 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
MA - Marocco 3
BD - Bangladesh 2
CL - Cile 2
LV - Lettonia 2
MM - Myanmar 2
NO - Norvegia 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AR - Argentina 1
CU - Cuba 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
PA - Panama 1
PY - Paraguay 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 39.528
Città #
Santa Clara 6.607
Fairfield 2.333
Dublin 1.520
Chandler 1.448
Warsaw 1.412
Woodbridge 1.094
Ashburn 1.001
Seattle 957
Cambridge 899
Singapore 835
Houston 810
Jacksonville 805
Wilmington 758
Lawrence 590
Altamura 526
Princeton 456
Hong Kong 372
Bern 361
Florence 359
Ann Arbor 334
Buffalo 291
Beijing 290
Melbourne 287
Boston 280
Boardman 244
Mumbai 239
Medford 228
San Diego 161
Moscow 148
Abidjan 113
Izmir 102
Shanghai 95
Helsinki 87
Norwalk 87
Kent 86
Dong Ket 67
Milan 66
Falls Church 61
Jakarta 60
Hillsboro 54
New York 52
Toronto 50
Yubileyny 50
Andover 40
Redwood City 38
Seoul 35
Philadelphia 34
Barcelona 31
Dearborn 30
Falkenstein 30
Los Angeles 28
Ravenna 28
Rome 27
Frankfurt Am Main 25
West Jordan 24
London 20
Siena 20
Verona 18
Arezzo 17
Redmond 16
Lappeenranta 15
Brussels 13
Guangzhou 13
Laurel 13
São Paulo 13
Bologna 12
Naples 11
Phoenix 11
Rouen 11
Auburn Hills 10
Campinas 10
Napoli 10
Munich 9
Nanjing 9
Scandicci 9
Padova 8
San Mateo 8
Sydney 8
Atlanta 7
Bientina 7
Parma 7
Pune 7
Tappahannock 7
Chicago 6
Frankfurt am Main 6
Paris 6
Athens 5
Berlin 5
Castellammare di Stabia 5
Cernusco sul Naviglio 5
Chennai 5
Itapeva 5
Leipzig 5
Menlo Park 5
Montottone 5
Morrovalle 5
Old Bridge 5
Osaka 5
Ottawa 5
Prescot 5
Totale 27.452
Nome #
Immune dysfunction in Rett syndrome patients revealed by high levels of serum anti-N(Glc) IgM antibody fraction 285
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. 283
Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae 277
A novel DNA/histone H4 peptide complex detects autoantibodies in systemic lupus erythematosus sera 267
Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis 262
Characterization of NF-κB Reporter U937 Cells and Their Application for the Detection of Inflammatory Immune-Complexes 241
pH Regulated Formation of Side Products in the Reductive Amination Approach for Differential Labeling of Peptides in Relative Quantitative Experiments. 227
Biosensor analysis of anti citrullinated protein/peptide antibodies (ACPA) affinity 224
Increased 5-oxo-MEHP in autism: an innovative PHTALOX-metabolites HPLC urine diagnostic technique to assess DEHP exposure. 212
Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium 203
An Optimized Scalable Fully Automated Solid-Phase Microwave-Assisted cGMP-Ready Process for the Preparation of Eptifibatide 167
Peptides as Active Ingredients: a Challenge for Cosmeceutical Industry 157
A convenient microwave-enhanced solid-phase synthesis of difficult peptide sequences: case study of Gramicidin A and CSF114(Glc). 154
Glycopeptide-Based Antibody Detection in Multiple Sclerosis by Surface Plasmon Resonance 152
Post-translationally modified peptides efficiently mimicking neo-antigens: A challenge for theragnostics of autoimmune diseases. 146
Fine Mapping of Glutamate Decarboxylase 65 Epitopes Reveals Dependency on Hydrophobic Amino Acids for Specific Interactions 144
Bioactive peptides and compositions comprising them / Peptidi bioattivi e composizioni che li contengono 142
Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein. 140
Antibodies to post-translationally modified mitochondrial peptide PDC-E2(167-184) in type 1 diabetes 139
Just a spoonful of sugar: Short glycans affect protein properties and functions 139
Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at Cα of selected amino acids 139
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 137
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 137
An Optimised Di-Boronate-ChemMatrix Affinity Chromatography to Trap Deoxyfructosylated Peptides as Biomarkers of Glycation 136
A NEW CLASS OF PSEUDOPEPTIDE ANTAGONISTS OF THE KININ B1 RECEPTOR CONTAINING ALKYL SPACERS 135
PEPTIDI AVENTI ATTIVITA’ ANTAGONISTA DEL’UROTENSINA-II. 135
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope 135
UROTENSIN-II RECEPTOR PEPTIDE AGONISTS 132
Synthetic peptides in the diagnosis of HIV infection 132
Fmoc-protected iminosugar modified asparagine derivatives as building blocks for glycomimetics-containing peptides 132
Autoantibodies to N-glucosylated peptide sequons in Rett syndrome: the first insight to disclose an autoimmune mechanism 129
1,4-Disubstituted-[1,2,3]triazolyl-containing analogs of MTII – design, synthesis, conformational analysis, and biological activity 129
N-triazinylammonium tetrafluoroborates. A new generation of efficient coupling reagents useful for peptide synthesis 128
Stabilization of beta-turn conformation in melanocortin like peptide by click side chain-to-side chain cyclization 128
Assessment of new 6Cl-HOBt based coupling reagents for peptide synthesis. Part 1: Coupling efficiency study 127
Therapeutic proteins immunogenicity: a peptide point of view 126
Optimization of Multiple Sclerosis Antigenic Probes by a Combinatorial Approach 126
Serpin A1 and the modulation of type I collagen turnover: effect of the C-terminal peptide 409-418 (SA1-III) in human dermal fibroblasts 126
Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques 125
Study of aberrant modifications in peptides as test bench to investigate the immunological response to non-enzymatic glycation 125
CROSS-REACTIVITY STUDIES OF RMOGED WITH SYNTHETIC PUTATIVE AUTOANTIGENS CSF114(GLC) AND [N31(GLC)]HMOG(30-50)IN MULTIPLE SCLEROSIS PATIENTS'SERA 124
Solvent independent conformational propensities of [1,2,3]triazolyl-bridged parathyroid hormone-related peptide-derived cyclo-nonapeptide analogues 123
A Multiple N-Glucosylated Peptide Epitope Efficiently Detecting Antibodies in Multiple Sclerosis 122
CONFORMATION-ACTIVITY RELATIONSHIP OF DESIGNED GLYCOPEPTIDES AS SYNTHETIC PROBES FOR THE DETECTION OF AUTOANTIBODIES, BIOMARKERS OF MULTIPLE SCLEROSIS 122
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 122
Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: Microwave-assisted synthesis of the peptide antigens and ELISA screening 120
Rett syndrome: An autoimmune disease? 120
SYNTHESIS OF A DICARBA- ANALOGUE OF OCTEOTRIDE KEEPING THE TYPE II BETA-TURN OF THE PHARMACOPHORE IN WATER SOLUTION 119
Does an Aberrant Glucosylation Trigger Autoimmunity in Multiple Sclerosis? 119
INVESTIGATION OF NEWLY SYNTHESIZED PEPTIDES BY CAPILLARY ZONE ELECTROPHORESIS/ELECTROSPRAY MASS SPECTROMETRY 118
[125I]His-Neurokinin A binds selectively to NK2 receptors of the B type in a rat small intestine smooth muscle membranes. 118
Development of an Efficient Multiple Sclerosis Diagnostic Technology Based on an Optical Glycopeptide Immunosensor 118
RACEMIZATION STUDIES OF FMOC-SER(TBU)-OH DURING STEPWISE CONTINUOUS-FLOW SOLID-PHASE PEPTIDE SYNTHESIS 116
G-ALPHA-S PROTEIN C TERMINAL ALPHA HELIX AT THE INTERFACE: DOES THE PLASMA MEMBRANE PLAY A CRITICAL ROLE IN THE G-ALPHA-S PROTEIN FUNCTIONALITY? 116
SPPS of glucosylated multiple antigen peptides (MAPs) as synthetic probes for detection of autoantibodies in multiple sclerosis patients' sera. 116
A retro-inverso analogue of the antiviral octapeptide C8 inhibits feline immunodeficiency virus in serum. 116
Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy 116
Identification of new autoantigens in Multiple Sclerosis by glycopeptide libraries 115
UROTENSIN II RECEPTOR LIGANDS. FROM AGONIST TO ANTAGONIST ACTIVITY 114
Cross-reactive peptide epitopes of Enterovirus Coxsackie B4 and human Glutamic Acid Decarboxylase detecting antibodies in Latent Autoimmune Diabetes in Adults versus Type 1 Diabetes 114
A new potent urotensin II receptor peptide agonist containing a Pen residue at disulfide bridge. 113
SPPS OF DIFFICULT SEQUENCES: A COMPARISON OF CHEMICAL CONDITIONS, SYNTHETIC STRATEGIES AND ON-LINE MONITORING 111
Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus 111
On-resin microwave-assisted copper-catalyzed azide-alkyne cycloaddition of H1-relaxin B single chain ‘stapled’ analogues 111
Synthesis of building blocks for the synthesis of glycopeptides to detect anti-ganglioside antibodies in Amyotrophic Lateral Sclerosis. 111
Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation 111
Antiviral activity against SARS-CoV-2 of conformationally constrained helical peptides derived from angiotensin-converting enzyme-2. 110
Feline immunodeficiency virus plasma load reduction by a retroinverso octapeptide reproducing the Trp-rich motif of the transmembrane glycoprotein 110
IgG and IgM antibodies to the refolded MOG(1-125) extracellular domain in humans. 110
Cross-reactivity studies of rMOG(ED) with synthetic putative autoantigens CSF114(Glc) and [N-31(Glc)]hMOG(30-50) in multiple sclerosis patients' sera. 110
In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain. 110
Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. 110
Design, Synthesis and Conformational Studies of [DOTA]-Octreotide Analogues Containing [1,2,3]Triazolyl as a Disulfide Mimetic 110
PROBING THE TOPOLOGICAL ARRANGEMENT OF THE N- AND C-TERMINAL RESIDUES OF BRADYKININ FOR AGONIST ACTIVITY AT THE B1 RECEPTOR 109
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc) 109
On-resin head-to-tail cyclization of cyclotetrapeptides: optimization of crucial parameters 108
Modeling interaction between gp120 HIV protein and CCR5 receptor 108
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 108
Surface plasmon resonance method to evaluate anti-citrullinated protein/peptide antibody affinity to citrullinated peptides 108
ASSESSMENT OF NEW 6-CL-HOBT BASED COUPLING REAGENTS FOR PEPTIDE SYNTHESIS. PART 2: RACEMIZATION STUDIES 107
SYNTHETIC PEPTIDES OF THE A-SUBUNIT OF GS PROTEIN INHIBIT RECEPTOR MEDIATED ADENYLYL CYCLASE 107
CALCIUM-MEDIATED ENDOTHELIN SIGNALING IN C6 RAT GLIOMA CELLS 107
DESIGN, SYNTHESIS AND CONFORMATIONAL ANALYSIS OF HGM-CSF[13-31]-GLY-PRO-GLY-[103-116] 107
Dissection of seroreactivity against the tryptophan-rich motif of feline immunodeficiency virus transmembrane glycoprotein. 107
Production of peptides as generic drugs: A patent landscape of octreotide 107
Humoral response against LL-37 in psoriatic disease 107
Antibody Recognition in multiple sclerosis and rett syndrome using a collection of linear and cyclic N-glucosylated antigenic probes 107
Structural studies on Hgr3 orphan receptor ligand Prolactin-Releasing Peptide 106
Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses 106
Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development 106
Conventional and microwave-assisted SPPS approach: a comparative synthesis of PTHrP(1–34)NH2 106
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 106
Histone Protein Epitope Mapping for Autoantibody Recognition in Rheumatoid Arthritis 105
First synthesis of both pure diastereomeric N6-(1,2-dithiolane-(3R or S)-pentanoyl)-N2-Fmoc-L-Lys-OH for Fmoc/tBu SPPS 105
Glycoreplica peptides to investigate molecular mechanisms of immune-mediated physiological versus pathological conditions 105
Electrochemical investigation of melittin reconstituted into a mercury-supported lipid bilayer 104
Ribose building block for the synthesis of glycopeptides to fishing out antibodies in autoimmune diseases. 104
STRUCTURE-ACTIVITY ANALYSIS OF C-TERMINAL ENDOTHELIN ANALOGUES 103
Synthesis, structural aspects, and bioactivity of the marine cyclopeptide hymenamide C 103
Nuovi peptidi glicosilati 103
Totale 13.254
Categoria #
all - tutte 116.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.391 0 0 0 0 0 0 498 629 480 292 390 102
2020/20213.290 268 196 235 252 127 475 158 337 270 438 209 325
2021/20222.941 97 392 209 155 112 90 115 196 89 96 590 800
2022/20237.340 738 1.399 261 413 581 1.279 879 339 728 47 240 436
2023/20242.549 134 348 503 130 123 236 214 431 39 99 171 121
2024/202514.508 733 1.968 1.123 2.524 5.194 2.961 5 0 0 0 0 0
Totale 40.081